Contineum Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Contineum Therapeutics, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 26, 2026.
NASDAQ
Contineum Therapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Contineum Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 26, 2025, featuring director elections and ratification of the company's independent accounting firm.